Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis.

چکیده

Anti-vascular endothelial growth factor (anti-VEGF) therapy is the standard of care for reetinsl vein occlusion (RVO)-related macular edema, yet its influence on subfoveal choroidal thickness (SFCT,) a potential adjunctive biomarker of disease activity and treatment response, remains uncertain. We…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط